73 annotations
Page 2 of 4
Olink
(No comment added)
Transcript
2023 Q3
27 Nov 23
What was instrument growth in China versus rest of world
(No comment added)
Transcript
2023 Q3
17 Nov 23
I was pleasantly surprised that a real focus on a better environment for foreign companies
(No comment added)
Transcript
2023 Q3
17 Nov 23
One is the Chair of the U.S. China Business Council
(No comment added)
Transcript
2023 Q3
17 Nov 23
4% to 6% market growth. I don't think there's any controversy that we're going to grow meaningfully faster
(No comment added)
Transcript
2023 Q3
17 Nov 23
raise the long-term target to 7% to 9%
(No comment added)
Transcript
2023 Q3
17 Nov 23
long-term target to 7% to 9%
(No comment added)
Transcript
2023 Q3
17 Nov 23
2024 revenue dollars will be very similar to 2023.
(No comment added)
Transcript
2023 Q3
17 Nov 23
how to frame 2024
(No comment added)
Transcript
2023 Q3
17 Nov 23
dividends, a 17% increase over 2022.
(No comment added)
Transcript
2023 Q3
17 Nov 23
capital deployment, our guidance includes $3 billion of share buybacks, which were already completed in January, $3.7 billion in acquisitions completed this year and $3.1 billion committed to the acquisition of Olink, which we expect to close in 2024.
(No comment added)
Transcript
2023 Q3
17 Nov 23
Laboratory Products and Biopharma Services
(No comment added)
Transcript
2023 Q3
17 Nov 23
Specialty Diagnostics
(No comment added)
Transcript
2023 Q3
17 Nov 23
Life Sciences Solutions
(No comment added)
Transcript
2023 Q3
17 Nov 23
Analytical Instruments segment
(No comment added)
Transcript
2023 Q3
17 Nov 23
Our leverage ratio at the end of the quarter was 3.2x gross debt to adjusted EBITDA and 2.7x on a net debt basis.
(No comment added)
Transcript
2023 Q3
17 Nov 23
$35.3 billion of total debt.
(No comment added)
Transcript
2023 Q3
17 Nov 23
$6.2 billion in cash
(No comment added)
Transcript
2023 Q3
17 Nov 23
we delivered $5.69 of adjusted EPS, a 12% increase over Q3 last year
(No comment added)
Transcript
2023 Q3
17 Nov 23
our strategy consists of 3 pillars
(No comment added)
Transcript
2023 Q3
17 Nov 23